Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Myeloid 1

Conditions

Pancreatic Neoplasms 2Genetic Predisposition to Disease 1Gallbladder Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Mutation × Gastrointestinal × Clear all
NCT05657210 2022-12-20

Prognostic Value of Each Codon-specific KRAS Mutation in Colorectal Cancer

Seoul National University Bundang Hospital

Completed
2,203 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05604573 2022-11-03

DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer

Seoul National University Hospital

Unknown
150 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03982446 2021-02-12

PaMPA

Hellenic Cooperative Oncology Group

Completed
549 enrolled
Gastrointestinal

Pancreatic Neoplasms, Genetic Predisposition to Disease

NCT03772132 2018-12-11

Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
100 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡